<?xml version="1.0" encoding="UTF-8"?>
<ref id="R21">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Furie</surname>
    <given-names>R</given-names>
   </string-name>, 
   <string-name>
    <surname>Khamashta</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Merrill</surname>
    <given-names>JT</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Anifrolumab, an anti-interferon-α receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus</article-title>. 
  <source>Arthritis Rheumatol</source>
  <year>2017</year>;
  <volume>69</volume>:
  <fpage>376</fpage>–
  <lpage>86</lpage>. 
  <pub-id pub-id-type="doi">10.1002/art.39962</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28130918?>
  <pub-id pub-id-type="pmid">28130918</pub-id>
 </mixed-citation>
</ref>
